Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1975 1
1978 1
1979 1
1981 4
1983 6
1984 1
1985 2
1988 1
1989 1
1990 2
1991 1
1992 3
1993 4
1994 1
1996 1
1998 1
1999 3
2000 3
2001 5
2002 1
2003 7
2004 15
2005 30
2006 21
2007 25
2008 31
2009 36
2010 28
2011 49
2012 48
2013 75
2014 58
2015 62
2016 62
2017 60
2018 64
2019 74
2020 105
2021 134
2022 100
2023 23
Text availability
Article attribute
Article type
Publication date

Search Results

1,016 results
Results by year
Filters applied: . Clear all
Page 1
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Majzner RG, Ramakrishna S, Yeom KW, Patel S, Chinnasamy H, Schultz LM, Richards RM, Jiang L, Barsan V, Mancusi R, Geraghty AC, Good Z, Mochizuki AY, Gillespie SM, Toland AMS, Mahdi J, Reschke A, Nie EH, Chau IJ, Rotiroti MC, Mount CW, Baggott C, Mavroukakis S, Egeler E, Moon J, Erickson C, Green S, Kunicki M, Fujimoto M, Ehlinger Z, Reynolds W, Kurra S, Warren KE, Prabhu S, Vogel H, Rasmussen L, Cornell TT, Partap S, Fisher PG, Campen CJ, Filbin MG, Grant G, Sahaf B, Davis KL, Feldman SA, Mackall CL, Monje M. Majzner RG, et al. Among authors: ramakrishna s. Nature. 2022 Mar;603(7903):934-941. doi: 10.1038/s41586-022-04489-4. Epub 2022 Feb 7. Nature. 2022. PMID: 35130560 Free PMC article. Clinical Trial.
Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials.
Parham S, Kharazi AZ, Bakhsheshi-Rad HR, Nur H, Ismail AF, Sharif S, RamaKrishna S, Berto F. Parham S, et al. Among authors: ramakrishna s. Antioxidants (Basel). 2020 Dec 21;9(12):1309. doi: 10.3390/antiox9121309. Antioxidants (Basel). 2020. PMID: 33371338 Free PMC article. Review.
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Spiegel JY, Patel S, Muffly L, Hossain NM, Oak J, Baird JH, Frank MJ, Shiraz P, Sahaf B, Craig J, Iglesias M, Younes S, Natkunam Y, Ozawa MG, Yang E, Tamaresis J, Chinnasamy H, Ehlinger Z, Reynolds W, Lynn R, Rotiroti MC, Gkitsas N, Arai S, Johnston L, Lowsky R, Majzner RG, Meyer E, Negrin RS, Rezvani AR, Sidana S, Shizuru J, Weng WK, Mullins C, Jacob A, Kirsch I, Bazzano M, Zhou J, Mackay S, Bornheimer SJ, Schultz L, Ramakrishna S, Davis KL, Kong KA, Shah NN, Qin H, Fry T, Feldman S, Mackall CL, Miklos DB. Spiegel JY, et al. Among authors: ramakrishna s. Nat Med. 2021 Aug;27(8):1419-1431. doi: 10.1038/s41591-021-01436-0. Epub 2021 Jul 26. Nat Med. 2021. PMID: 34312556 Free PMC article. Clinical Trial.
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.
Fry TJ, Shah NN, Orentas RJ, Stetler-Stevenson M, Yuan CM, Ramakrishna S, Wolters P, Martin S, Delbrook C, Yates B, Shalabi H, Fountaine TJ, Shern JF, Majzner RG, Stroncek DF, Sabatino M, Feng Y, Dimitrov DS, Zhang L, Nguyen S, Qin H, Dropulic B, Lee DW, Mackall CL. Fry TJ, et al. Among authors: ramakrishna s. Nat Med. 2018 Jan;24(1):20-28. doi: 10.1038/nm.4441. Epub 2017 Nov 20. Nat Med. 2018. PMID: 29155426 Free PMC article. Clinical Trial.
Collagen-based biomaterials for biomedical applications.
Rezvani Ghomi E, Nourbakhsh N, Akbari Kenari M, Zare M, Ramakrishna S. Rezvani Ghomi E, et al. Among authors: ramakrishna s. J Biomed Mater Res B Appl Biomater. 2021 Dec;109(12):1986-1999. doi: 10.1002/jbm.b.34881. Epub 2021 May 24. J Biomed Mater Res B Appl Biomater. 2021. PMID: 34028179 Review.
Different Methods of Delivering CRISPR/Cas9 Into Cells.
Chandrasekaran AP, Song M, Kim KS, Ramakrishna S. Chandrasekaran AP, et al. Among authors: ramakrishna s. Prog Mol Biol Transl Sci. 2018;159:157-176. doi: 10.1016/bs.pmbts.2018.05.001. Epub 2018 Jun 12. Prog Mol Biol Transl Sci. 2018. PMID: 30340786 Review.
The role of deubiquitinating enzymes in cancer drug resistance.
Tanguturi P, Kim KS, Ramakrishna S. Tanguturi P, et al. Among authors: ramakrishna s. Cancer Chemother Pharmacol. 2020 Apr;85(4):627-639. doi: 10.1007/s00280-020-04046-8. Epub 2020 Mar 7. Cancer Chemother Pharmacol. 2020. PMID: 32146496 Review.
Addressing sustainability gaps.
Ramakrishna S, Jose R. Ramakrishna S, et al. Sci Total Environ. 2022 Feb 1;806(Pt 3):151208. doi: 10.1016/j.scitotenv.2021.151208. Epub 2021 Oct 26. Sci Total Environ. 2022. PMID: 34715226
1,016 results